D'Orazio & Associates’s Sanofi SNY Stock Holding History

D'Orazio & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-287	Closed	-$14K	–	614
2021 Q3	$14K	Buy	+287	New	+$14.6K	﹤0.01%	483

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

D'Orazio & Associates's SNY Position: Q4 2021 in Review

D'Orazio & Associates sold out of Sanofi (SNY) in Q4 2021, closing a stake of 287 shares — an estimated $14K sold.

D'Orazio & Associates first reported a position in SNY in Q3 2021 and held it in 1 quarter. The position peaked at $14K in Q3 2021. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

D'Orazio & Associates reported no remaining Sanofi position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 287 Sanofi shares in Q4 2021, an estimated $14K.
D'Orazio & Associates first reported a position in Sanofi in Q3 2021 and held it in 1 quarter.
D'Orazio & Associates's Sanofi position peaked at $14K in Q3 2021.
624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.